OL Chemicals and Pharmaceuticals stock surged up to 4.59 per cent at Rs 415.15 per share on the BSE in Wednesday’s intraday trade

IOL Chemicals zooms 5% on drug nod from European regulator: details here

IOL Chemicals & Pharmaceuticals surged 7.76% to Rs 441.05 after China’s National Medical Products Administration (NMPA) approved the company’s Fenofibrate drug.

IOL Chem soars on China approval for cholesterol drug

Pantoprazole is used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD)

IOL Chemicals share price up 6% on bagging CEP certificate for Pantoprazole

The stock rose as much as 13.81% during the day on the NSE.

IOL Chemicals Shares Surge As Brazilian Watchdog Ends Audit With No Observation

IOL Chemicals Consolidated March 2023 Net Sales at Rs 587.21 crore, up 2.57% Y-o-Y

Ashish Kacholia owned 11,53,566 equity shares or a 1.97 per cent stake in IOL Chemical & Pharmaceuticals for the quarter ended in December 2022 quarter.

IOL Chemicals & Pharma shares: Ashish Kacholia signals exit from this multibagger stock

Buzzing stocks: TVS Motor, TCS, Britannia, NBCC, RailTel, Compucom Software, Cyient, Havells India, IOL Chemicals, SH Khelkar, Indigo Paints, Syrma SGS

Stocks that will see action on April 5, 2023

Sanjay Chaturvedi, CEO, IOL Chemicals & Pharmaceuticals discusses the company's Q3 earnings and outlook going forward. Listen in.

#sanjayharurvedi #iolchemicals #q3earnings #q3results #stockmarket #stockmarketupdates #cnbctv18 #businessnews  #businessnewstoday #businessnewsinenglish #sharemarkettoday  

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. #n18oc_business  Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 

You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

n18oc_business

Sanjay Chaturvedi Discusses IOL Chemicals' Q3FY23 Earnings | Your Stocks | CNBC-TV18

IOL Chemicals Standalone December 2022 Net Sales at Rs 523.48 crore, down 5.7% Y-o-Y

IOL Chemicals & Pharmaceuticals Ltd, Kaveri Seed Company Ltd, Suven Pharmaceuticals Ltd and Ajanta Pharma Ltd are among the other losers in the BSE’s ‘A’ group today, 26 December 2022.

Morepen Laboratories Ltd leads losers in ‘A’ group

Everest Kanto Cylinder Ltd, Shilpa Medicare Ltd, IOL Chemicals & Pharmaceuticals Ltd and Kennametal India Ltd are among the other gainers in the BSE’s ‘A’ group today, 23 December 2022.

Morepen Laboratories Ltd leads gainers in ‘A’ group

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

IOL Chemicals and Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals and bulk drugs.